Myasthenia gravis is an autoimmune disease that causes muscle weakness, particularly in the eyes, face, and throat, though it can affect muscles throughout the body. It occurs when the immune system mistakenly produces antibodies that interfere with the communication between nerves and muscles. Prevalence ranges from 15 to 20 per 100,000 people, and while there’s no cure, most people achieve significant improvement with treatment.
How Nerve-to-Muscle Communication Breaks Down
Every time you move a muscle, your nerves release a chemical messenger called acetylcholine. This messenger crosses a tiny gap between the nerve ending and the muscle fiber, latches onto receptors on the muscle surface, and triggers the muscle to contract. In myasthenia gravis, your immune system creates antibodies that attack those receptors or related proteins, reducing the number available to receive the signal. The result: your nerves fire normally, but the message doesn’t fully reach the muscle.
The most common target is the acetylcholine receptor itself. Antibodies can destroy these receptors, physically block acetylcholine from binding, or cause the muscle cell to pull the receptors inside and break them down. In a smaller subset of patients, the antibodies target different proteins that help maintain the structure of the nerve-muscle junction. These structural proteins keep receptors clustered where they need to be, so when they’re disrupted, receptor numbers drop even though the receptors themselves aren’t directly attacked. Either way, the end result is the same: weakened muscle contraction.
Who Gets Myasthenia Gravis
The disease can develop at any age, but it follows distinct patterns in men and women. In women, new cases peak around age 30 and again around age 50. In men, the incidence climbs steadily with age and is highest between 60 and 89. Women are more commonly affected at younger ages, while among older adults the gender gap narrows or reverses.
The reasons behind these patterns aren’t fully understood, but the connection to the thymus gland plays a role. The thymus, a small organ behind the breastbone that’s involved in immune system development, is abnormal in a significant number of people with myasthenia gravis. Some have an enlarged thymus, while about 10 to 15 percent have a thymoma, a tumor of the thymus. These thymus abnormalities are thought to contribute to the misdirected immune response.
Early Symptoms and How They Progress
The disease most often announces itself in the eyes. Drooping eyelids (ptosis) and double vision are the first symptoms in the majority of cases, and ocular symptoms appear at some point in 15 to 50 percent of all patients. A hallmark feature is that the weakness fluctuates. Your eyelid might droop more in the evening or after sustained reading, then improve after rest. This pattern of worsening with use and recovering with rest is one of the most distinctive clues.
Some people’s symptoms stay confined to the eyes, a form called ocular myasthenia gravis. But in 20 to 60 percent of those cases, the disease eventually spreads to other muscle groups, typically within the first two years. Generalized myasthenia gravis can affect muscles involved in chewing, swallowing, speaking, breathing, and moving the limbs. Speech may become nasal or slurred after prolonged talking. Chewing may become exhausting partway through a meal. Arm and leg weakness tends to affect muscles closer to the trunk, making overhead reaching or climbing stairs difficult.
How It’s Diagnosed
Diagnosis usually starts with a blood test for antibodies against acetylcholine receptors. This test catches about 82 percent of cases and is highly specific, meaning a positive result almost certainly confirms the disease (specificity around 98 percent). If that test comes back negative, a second blood test looks for antibodies against MuSK, a structural protein at the nerve-muscle junction. A third target, LRP4, can be tested when both are negative.
For people with eye symptoms, doctors sometimes use a simple bedside test: placing an ice pack on the closed eyelid for two minutes. Cold slows the breakdown of acetylcholine, temporarily improving the signal. If the drooping eyelid lifts noticeably, it strongly suggests myasthenia gravis. This ice test has a sensitivity of about 92 percent for detecting the condition in patients with ptosis and is especially useful as a quick screening tool because a negative result makes the diagnosis unlikely.
Nerve conduction studies and electromyography can also help. These tests stimulate a nerve repeatedly and measure whether the muscle response fades with each stimulation, a pattern characteristic of the disease. In some cases where blood tests are negative, more sensitive lab techniques using cell-based assays can detect antibodies that standard tests miss, with specificity approaching 100 percent.
Treatment: What to Expect
Treatment typically begins with a medication that boosts the amount of acetylcholine available at the nerve-muscle junction. This doesn’t address the underlying immune problem, but it improves muscle strength by giving the remaining receptors more chemical messenger to work with. Many people notice improvement in symptoms within 30 to 60 minutes of taking it.
If symptoms aren’t adequately controlled, the next step is immune-suppressing therapy. Corticosteroids are commonly used first because they work relatively quickly, often within weeks. Because long-term steroid use carries significant side effects, doctors typically add a second immune-suppressing medication that takes longer to kick in (sometimes months) but allows the steroid dose to be gradually reduced. The goal is to find the lowest combination that keeps symptoms controlled.
Newer biologic therapies have expanded options considerably, especially for people who don’t respond well to standard treatments. One class works by accelerating the breakdown of the harmful antibodies circulating in the blood. In a major clinical trial, patients receiving one of these treatments were nearly five times more likely to achieve meaningful improvement compared to placebo. Another class targets a part of the immune system called complement, which contributes to receptor destruction. These biologics are particularly useful because they can be matched to the specific type of antibody involved. For example, complement-blocking drugs work well when the antibodies activate the complement system, while antibody-degrading drugs work across all antibody types, making them suitable for the MuSK form of the disease where complement isn’t involved.
The Role of Thymus Surgery
Surgical removal of the thymus gland is recommended for patients who have a thymoma, regardless of how severe their myasthenia gravis is. But it’s also offered to many patients without a thymoma, particularly younger adults with generalized disease. Studies report full recovery rates of 30 to 55 percent after the surgery, and when partial improvement is included, over 85 percent of patients benefit.
Several factors predict better outcomes: younger age at the time of surgery, shorter time between symptom onset and the operation, female sex, and the absence of a thymoma on pathology. Patients with a normal or atrophic thymus on imaging tend to do particularly well. Recovery isn’t immediate. It typically takes months to years to see the full benefit, and many patients still need medication afterward, just at lower doses.
Myasthenic Crisis
The most dangerous complication is a myasthenic crisis, where weakness of the breathing muscles becomes severe enough to require mechanical ventilation. This is a medical emergency. Respiratory capacity dropping below about 20 to 25 milliliters per kilogram of body weight, or the inability to generate adequate breathing force, signals that a crisis is underway.
Infections are the most common trigger, responsible for about 38 percent of crises, with pneumonia and upper respiratory infections leading the list. Other triggers include surgery, pregnancy, abrupt changes in medication, extreme temperatures, sleep deprivation, and severe emotional stress. Recognizing worsening shortness of breath, difficulty speaking in full sentences, or a weak cough is critical for getting emergency care quickly.
Medications That Can Worsen Symptoms
Certain commonly prescribed drugs can dangerously aggravate myasthenia gravis or even unmask it in someone who hasn’t been diagnosed yet. The most important categories to be aware of include certain antibiotics (particularly fluoroquinolones, aminoglycosides, and macrolides), heart rhythm medications, some blood pressure drugs, and certain anesthetics used during surgery. These drugs interfere with nerve-to-muscle transmission through various mechanisms, compounding the existing deficit.
If you have myasthenia gravis, every prescriber you see, including dentists and urgent care providers, needs to know your diagnosis before giving you any new medication. Many people carry a medical alert card or bracelet listing their condition for this reason.